GB1553141A - Dosage unit for achieving an aversion against alcohol - Google Patents

Dosage unit for achieving an aversion against alcohol

Info

Publication number
GB1553141A
GB1553141A GB41625/77A GB4162577A GB1553141A GB 1553141 A GB1553141 A GB 1553141A GB 41625/77 A GB41625/77 A GB 41625/77A GB 4162577 A GB4162577 A GB 4162577A GB 1553141 A GB1553141 A GB 1553141A
Authority
GB
United Kingdom
Prior art keywords
achieving
dosage unit
against alcohol
aversion
aversion against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB41625/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of GB1553141A publication Critical patent/GB1553141A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
GB41625/77A 1976-10-09 1977-10-06 Dosage unit for achieving an aversion against alcohol Expired GB1553141A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2645709A DE2645709C2 (de) 1976-10-09 1976-10-09 Verwendung von 1-(4-Nitrophenyl)-2-methyl-4-nitroimidazol bei der Erzielung einer Aversion gegen Alkohol

Publications (1)

Publication Number Publication Date
GB1553141A true GB1553141A (en) 1979-09-19

Family

ID=5990108

Family Applications (1)

Application Number Title Priority Date Filing Date
GB41625/77A Expired GB1553141A (en) 1976-10-09 1977-10-06 Dosage unit for achieving an aversion against alcohol

Country Status (6)

Country Link
JP (1) JPS5347535A (it)
BE (1) BE859483A (it)
DE (1) DE2645709C2 (it)
FR (1) FR2366838A1 (it)
GB (1) GB1553141A (it)
IT (1) IT7947855A0 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5953811U (ja) * 1982-09-29 1984-04-09 石垣機工株式会社 ダイヤフラム付濾板における濾液の排出装置
JPH033407U (it) * 1989-06-02 1991-01-14

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1620043C3 (de) * 1966-10-15 1979-02-15 Merck Patent Gmbh, 6100 Darmstadt 1 -(p-Nitrophenyl)-4-nitroimidazole, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2145651A1 (de) * 1971-09-13 1973-03-22 Merck Patent Gmbh Verfahren zur herstellung von nitroimidazolen

Also Published As

Publication number Publication date
BE859483A (fr) 1978-04-07
FR2366838B1 (it) 1984-06-29
JPS5347535A (en) 1978-04-28
DE2645709A1 (de) 1978-04-13
DE2645709C2 (de) 1985-04-25
IT7947855A0 (it) 1979-02-01
FR2366838A1 (fr) 1978-05-05

Similar Documents

Publication Publication Date Title
JPS5287521A (en) Ionizing device for preecombustion
ZA772972B (en) Dispenser device
ZA77686B (en) Device for dispensing medicaments
JPS52103267A (en) Device for imparting volatile agent
CY1129A (en) Pharmaceutical dosage forms
JPS5394746A (en) Maintaining device
JPS5343991A (en) Suction device for injection
JPS5356889A (en) Plunger for injector
YU43437B (en) Process for obtaining tablets containing an active component with long lasting effect
JPS52105111A (en) Tertiary alcohol
IL51365A (en) Coccidiocidal composition for poultriy comprising monensin and meticlorpindol
GB1553141A (en) Dosage unit for achieving an aversion against alcohol
AU510234B2 (en) Antikickback device for chainsaws
YU114877A (en) Device for immediate connection
JPS5335192A (en) Coronaashielding device for strainninsulator device
JPS5313300A (en) Markinggoff device for largeesized parts
JPS5325579A (en) Pharmaceutical compound
JPS5372397A (en) Device for taking out small quantity
JPS5380578A (en) Overrtravel device for microoswitch
JPS5321830A (en) Device for embanking
JPS52121074A (en) Device for corner spraying
IL48817A0 (en) Ionization device
JPS52149894A (en) Single use injector
JPS5361712A (en) Device for urging nozzle block
JPS5327403A (en) Device for forming record

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee